McKesson (MCK) Laps the Stock Market: Here's Why

01.04.25 00:00 Uhr

Werte in diesem Artikel
Aktien

622,20 EUR 0,40 EUR 0,06%

Indizes

5.633,1 PKT 21,2 PKT 0,38%

The most recent trading session ended with McKesson (MCK) standing at $672.99, reflecting a +0.74% shift from the previouse trading day's closing. This move outpaced the S&P 500's daily gain of 0.55%. Meanwhile, the Dow gained 1.01%, and the Nasdaq, a tech-heavy index, lost 0.14%.The prescription drug distributor's shares have seen an increase of 4.34% over the last month, surpassing the Medical sector's loss of 3.93% and the S&P 500's loss of 6.22%.Investors will be eagerly watching for the performance of McKesson in its upcoming earnings disclosure. The company is expected to report EPS of $9.81, up 58.74% from the prior-year quarter. At the same time, our most recent consensus estimate is projecting a revenue of $93.69 billion, reflecting a 22.7% rise from the equivalent quarter last year.For the full year, the Zacks Consensus Estimates are projecting earnings of $32.76 per share and revenue of $360.63 billion, which would represent changes of +19.39% and +16.73%, respectively, from the prior year.Investors should also note any recent changes to analyst estimates for McKesson. These revisions help to show the ever-changing nature of near-term business trends. As such, positive estimate revisions reflect analyst optimism about the company's business and profitability.Our research demonstrates that these adjustments in estimates directly associate with imminent stock price performance. We developed the Zacks Rank to capitalize on this phenomenon. Our system takes these estimate changes into account and delivers a clear, actionable rating model.The Zacks Rank system ranges from #1 (Strong Buy) to #5 (Strong Sell). It has a remarkable, outside-audited track record of success, with #1 stocks delivering an average annual return of +25% since 1988. Over the past month, the Zacks Consensus EPS estimate remained stagnant. McKesson presently features a Zacks Rank of #3 (Hold).In terms of valuation, McKesson is presently being traded at a Forward P/E ratio of 20.39. This expresses a premium compared to the average Forward P/E of 16.56 of its industry.One should further note that MCK currently holds a PEG ratio of 1.43. This metric is used similarly to the famous P/E ratio, but the PEG ratio also takes into account the stock's expected earnings growth rate. As the market closed yesterday, the Medical - Dental Supplies industry was having an average PEG ratio of 1.8.The Medical - Dental Supplies industry is part of the Medical sector. With its current Zacks Industry Rank of 77, this industry ranks in the top 31% of all industries, numbering over 250.The Zacks Industry Rank evaluates the power of our distinct industry groups by determining the average Zacks Rank of the individual stocks forming the groups. Our research shows that the top 50% rated industries outperform the bottom half by a factor of 2 to 1.Be sure to use Zacks.com to monitor all these stock-influencing metrics, and more, throughout the forthcoming trading sessions.Zacks Names #1 Semiconductor StockIt's only 1/9,000th the size of NVIDIA which skyrocketed more than +800% since we recommended it. NVIDIA is still strong, but our new top chip stock has much more room to boom.With strong earnings growth and an expanding customer base, it's positioned to feed the rampant demand for Artificial Intelligence, Machine Learning, and Internet of Things. Global semiconductor manufacturing is projected to explode from $452 billion in 2021 to $803 billion by 2028.See This Stock Now for Free >>Want the latest recommendations from Zacks Investment Research? Today, you can download 7 Best Stocks for the Next 30 Days. Click to get this free report McKesson Corporation (MCK): Free Stock Analysis ReportThis article originally published on Zacks Investment Research (zacks.com).Zacks Investment ResearchWeiter zum vollständigen Artikel bei Zacks

In eigener Sache

Übrigens: McKesson und andere US-Aktien sind bei finanzen.net ZERO sogar bis 23 Uhr handelbar (ohne Ordergebühren, zzgl. Spreads). Jetzt kostenlos Depot eröffnen und als Geschenk eine Gratisaktie erhalten.

Ausgewählte Hebelprodukte auf McKesson

Mit Knock-outs können spekulative Anleger überproportional an Kursbewegungen partizipieren. Wählen Sie einfach den gewünschten Hebel und wir zeigen Ihnen passende Open-End Produkte auf McKesson

NameHebelKOEmittent
NameHebelKOEmittent
Wer­bung

Quelle: Zacks

Nachrichten zu McKesson Corp.

Wer­bung

Analysen zu McKesson Corp.

DatumRatingAnalyst
05.08.2019McKesson Peer PerformWolfe Research
26.10.2018McKesson Equal WeightBarclays Capital
20.07.2018McKesson NeutralRobert W. Baird & Co. Incorporated
08.03.2018McKesson Equal WeightBarclays Capital
02.02.2018McKesson NeutralMizuho
DatumRatingAnalyst
23.01.2018McKesson BuyNeedham & Company, LLC
04.12.2017McKesson BuyDeutsche Bank AG
01.11.2017McKesson BuyNeedham & Company, LLC
25.10.2017McKesson BuyNeedham & Company, LLC
19.09.2017McKesson OutperformRobert W. Baird & Co. Incorporated
DatumRatingAnalyst
05.08.2019McKesson Peer PerformWolfe Research
26.10.2018McKesson Equal WeightBarclays Capital
20.07.2018McKesson NeutralRobert W. Baird & Co. Incorporated
08.03.2018McKesson Equal WeightBarclays Capital
02.02.2018McKesson NeutralMizuho
DatumRatingAnalyst

Keine Analysen im Zeitraum eines Jahres in dieser Kategorie verfügbar.

Eventuell finden Sie Nachrichten die älter als ein Jahr sind im Archiv

Um die Übersicht zu verbessern, haben Sie die Möglichkeit, die Analysen für McKesson Corp. nach folgenden Kriterien zu filtern.

Alle: Alle Empfehlungen

Buy: Kaufempfehlungen wie z.B. "kaufen" oder "buy"
Hold: Halten-Empfehlungen wie z.B. "halten" oder "neutral"
Sell: Verkaufsempfehlungn wie z.B. "verkaufen" oder "reduce"
mehr Analysen